1 Study Coverage 1.1 Xeloda Product Introduction 1.2 Market by Type 1.2.1 Global Xeloda Market Size Growth Rate by Type 1.2.2 500 mg 1.2.3 150 mg 1.3 Market by Application 1.3.1 Global Xeloda Market Size Growth Rate by Application 1.3.2 Breast Cancer 1.3.3 Colorectal cancer 1.3.4 Stomach Cancer 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Xeloda Market Size, Estimates and Forecasts 2.1.1 Global Xeloda Revenue 2016-2027 2.1.2 Global Xeloda Sales 2016-2027 2.2 Global Xeloda, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Xeloda Historical Market Size by Region (2016-2021) 2.3.1 Global Xeloda Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Xeloda Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Xeloda Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Xeloda Sales Forecast by Region (2022-2027) 2.4.2 Global Xeloda Revenue Forecast by Region (2022-2027) 3 Global Xeloda Competitor Landscape by Players 3.1 Global Top Xeloda Manufacturers by Sales 3.1.1 Global Xeloda Sales by Manufacturer (2016-2021) 3.1.2 Global Xeloda Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Xeloda Manufacturers by Revenue 3.2.1 Key Xeloda Manufacturers Covered: Ranking by Revenue 3.2.2 Global Xeloda Revenue by Manufacturers (2016-2021) 3.2.3 Global Xeloda Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Xeloda Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Xeloda Revenue in 2020 3.2.6 Global Xeloda Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Xeloda Price by Manufacturers 3.4 Global Xeloda Manufacturing Base Distribution, Product Types 3.4.1 Xeloda Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Xeloda Product Type 3.4.3 Date of International Manufacturers Enter into Xeloda Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Xeloda Market Size by Type (2016-2021) 4.1.1 Global Xeloda Sales by Type (2016-2021) 4.1.2 Global Xeloda Revenue by Type (2016-2021) 4.1.3 Xeloda Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Xeloda Market Size Forecast by Type (2022-2027) 4.2.1 Global Xeloda Sales Forecast by Type (2022-2027) 4.2.2 Global Xeloda Revenue Forecast by Type (2022-2027) 4.2.3 Xeloda Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Xeloda Market Size by Application (2016-2021) 5.1.1 Global Xeloda Sales by Application (2016-2021) 5.1.2 Global Xeloda Revenue by Application (2016-2021) 5.1.3 Xeloda Price by Application (2016-2021) 5.2 Xeloda Market Size Forecast by Application (2022-2027) 5.2.1 Global Xeloda Sales Forecast by Application (2022-2027) 5.2.2 Global Xeloda Revenue Forecast by Application (2022-2027) 5.2.3 Global Xeloda Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Xeloda Market Size YoY Growth 2016-2027 6.1.1 China Xeloda Sales YoY Growth 2016-2027 6.1.2 China Xeloda Revenue YoY Growth 2016-2027 6.1.3 China Xeloda Market Share in Global Market 2016-2027 6.2 China Xeloda Market Size by Players (International and Local Players) 6.2.1 China Top Xeloda Players by Sales (2016-2021) 6.2.2 China Top Xeloda Players by Revenue (2016-2021) 6.3 China Xeloda Historic Market Review by Type (2016-2021) 6.3.1 China Xeloda Sales Market Share by Type (2016-2021) 6.3.2 China Xeloda Revenue Market Share by Type (2016-2021) 6.3.3 China Xeloda Price by Type (2016-2021) 6.4 China Xeloda Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Xeloda Sales Forecast by Type (2022-2027) 6.4.2 China Xeloda Revenue Forecast by Type (2022-2027) 6.4.3 China Xeloda Price Forecast by Type (2022-2027) 6.5 China Xeloda Historic Market Review by Application (2016-2021) 6.5.1 China Xeloda Sales Market Share by Application (2016-2021) 6.5.2 China Xeloda Revenue Market Share by Application (2016-2021) 6.5.3 China Xeloda Price by Application (2016-2021) 6.6 China Xeloda Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Xeloda Sales Forecast by Application (2022-2027) 6.6.2 China Xeloda Revenue Forecast by Application (2022-2027) 6.6.3 China Xeloda Price Forecast by Application (2022-2027) 7 North America 7.1 North America Xeloda Market Size YoY Growth 2016-2027 7.2 North America Xeloda Market Facts & Figures by Country 7.2.1 North America Xeloda Sales by Country (2016-2021) 7.2.2 North America Xeloda Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 7.2.5 Mexico 8 Asia Pacific 8.1 Asia Pacific Xeloda Market Size YoY Growth 2016-2027 8.2 Asia Pacific Xeloda Market Facts & Figures by Region 8.2.1 Asia Pacific Xeloda Sales by Region (2016-2021) 8.2.2 Asia Pacific Xeloda Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Thailand 8.2.10 Malaysia 8.2.11 Philippines 8.2.12 Vietnam 9 Europe 9.1 Europe Xeloda Market Size YoY Growth 2016-2027 9.2 Europe Xeloda Market Facts & Figures by Country 9.2.1 Europe Xeloda Sales by Country (2016-2021) 9.2.2 Europe Xeloda Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 UK 9.2.6 Italy 10 Latin America 10.1 Latin America Xeloda Market Size YoY Growth 2016-2027 10.2 Latin America Xeloda Market Facts & Figures by Country 10.2.1 Latin America Xeloda Sales by Country (2016-2021) 10.2.2 Latin America Xeloda Revenue by Country (2016-2021) 10.2.3 Brazil 11 Middle East and Africa 11.1 Middle East and Africa Xeloda Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Xeloda Market Facts & Figures by Country 11.2.1 Middle East and Africa Xeloda Sales by Country (2016-2021) 11.2.2 Middle East and Africa Xeloda Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 GCC Countries 11.2.5 Egypt 11.2.6 South Africa 12 Company Profiles 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Description and Business Overview 12.1.3 Roche Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Xeloda Products Offered 12.1.5 Roche Recent Development 12.2 Teva 12.2.1 Teva Corporation Information 12.2.2 Teva Description and Business Overview 12.2.3 Teva Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Teva Xeloda Products Offered 12.2.5 Teva Recent Development 12.3 Mylan 12.3.1 Mylan Corporation Information 12.3.2 Mylan Description and Business Overview 12.3.3 Mylan Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Mylan Xeloda Products Offered 12.3.5 Mylan Recent Development 12.4 Hikma 12.4.1 Hikma Corporation Information 12.4.2 Hikma Description and Business Overview 12.4.3 Hikma Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Hikma Xeloda Products Offered 12.4.5 Hikma Recent Development 12.5 Hengrui Medicine 12.5.1 Hengrui Medicine Corporation Information 12.5.2 Hengrui Medicine Description and Business Overview 12.5.3 Hengrui Medicine Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Hengrui Medicine Xeloda Products Offered 12.5.5 Hengrui Medicine Recent Development 12.6 Cipla 12.6.1 Cipla Corporation Information 12.6.2 Cipla Description and Business Overview 12.6.3 Cipla Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Cipla Xeloda Products Offered 12.6.5 Cipla Recent Development 12.7 Reliance Group 12.7.1 Reliance Group Corporation Information 12.7.2 Reliance Group Description and Business Overview 12.7.3 Reliance Group Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Reliance Group Xeloda Products Offered 12.7.5 Reliance Group Recent Development 12.8 Hetero 12.8.1 Hetero Corporation Information 12.8.2 Hetero Description and Business Overview 12.8.3 Hetero Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Hetero Xeloda Products Offered 12.8.5 Hetero Recent Development 12.11 Roche 12.11.1 Roche Corporation Information 12.11.2 Roche Description and Business Overview 12.11.3 Roche Xeloda Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Roche Xeloda Products Offered 12.11.5 Roche Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Xeloda Industry Trends 13.2 Xeloda Market Drivers 13.3 Xeloda Market Challenges 13.4 Xeloda Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Xeloda Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Xeloda Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 500 mg Table 3. Major Manufacturers of 150 mg Table 4. Global Xeloda Market Size Growth Rate by Application (2021-2027) & (K MT) Table 5. Global Xeloda Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Xeloda Sales by Regions (2016-2021) & (K MT) Table 7. Global Xeloda Sales Market Share by Regions (2016-2021) Table 8. Global Xeloda Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Xeloda Sales Forecast by Region (2022-2027) & (K MT) Table 10. Global Xeloda Sales Market Share Forecast by Region (2022-2027) Table 11. Global Xeloda Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Xeloda Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Xeloda Sales by Manufacturers (2016-2021) (K MT) Table 14. Global Xeloda Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Xeloda Manufacturers by Revenue (US$ Million) in 2020 Table 16. Xeloda Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Xeloda Revenue Share by Manufacturers (2016-2021) Table 18. Global Xeloda Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Xeloda by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xeloda as of 2020) Table 20. Key Manufacturers Xeloda Price (2016-2021) (USD/MT) Table 21. Xeloda Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Xeloda Product Type Table 23. Date of International Manufacturers Enter into Xeloda Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Xeloda Sales by Type (2016-2021) (K MT) Table 26. Global Xeloda Sales Share by Type (2016-2021) Table 27. Global Xeloda Revenue by Type (2016-2021) (US$ Million) Table 28. Global Xeloda Revenue Share by Type (2016-2021) Table 29. Xeloda Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 30. Global Xeloda Sales Forecast by Type (2022-2027) & (K MT) Table 31. Global Xeloda Sales Market Share Forecast by Type (2022-2027) Table 32. Global Xeloda Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Xeloda Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Xeloda Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Xeloda Sales by Application (2016-2021) (K MT) Table 36. Global Xeloda Sales Share by Application (2016-2021) Table 37. Global Xeloda Revenue by Application (2016-2021) (US$ Million) Table 38. Global Xeloda Revenue Share by Application (2016-2021) Table 39. Xeloda Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 40. Global Xeloda Sales Forecast by Application (2022-2027) & (K MT) Table 41. Global Xeloda Sales Market Share Forecast by Application (2022-2027) Table 42. Global Xeloda Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Xeloda Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Xeloda Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 45. China Xeloda Sales (K MT) of Key Companies (2016-2021) Table 46. China Xeloda Sales Share by Company (2016-2021) Table 47. China Xeloda Revenue (US$ Million) by Company (2016-2021) Table 48. China Xeloda Revenue Share by Company (2016-2021) Table 49. China Xeloda Sales (K MT) by Type (2016-2021) Table 50. China Xeloda Sales Share by Type (2016-2021) Table 51. China Xeloda Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. China Xeloda Price (USD/MT) by Type (2016-2021) Table 53. China Xeloda Sales (K MT) by Type (2022-2027) Table 54. China Xeloda Sales Share by Type (2022-2027) Table 55. China Xeloda Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. China Xeloda Revenue Share by Type (2022-2027) Table 57. China Xeloda Price (USD/MT) by Type (2022-2027) Table 58. China Xeloda Sales (K MT) by Application (2016-2021) Table 59. China Xeloda Sales Share by Application (2016-2021) Table 60. China Xeloda Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. China Xeloda Price (USD/MT) by Application (2016-2021) Table 62. China Xeloda Sales (K MT) by Application (2022-2027) Table 63. China Xeloda Sales Share by Application (2022-2027) Table 64. China Xeloda Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. China Xeloda Revenue Share by Application (2022-2027) Table 66. China Xeloda Price (USD/MT) by Application (2022-2027) Table 67. North America Xeloda Sales by Country (2016-2021) & (K MT) Table 68. North America Xeloda Sales Market Share by Country (2016-2021) Table 69. North America Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Xeloda Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Xeloda Sales by Region (2016-2021) & (K MT) Table 72. Asia Pacific Xeloda Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Xeloda Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Xeloda Revenue Market Share by Region (2016-2021) Table 75. Europe Xeloda Sales by Country (2016-2021) & (K MT) Table 76. Europe Xeloda Sales Market Share by Country (2016-2021) Table 77. Europe Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Xeloda Revenue Market Share by Country (2016-2021) Table 79. Latin America Xeloda Sales by Country (2016-2021) & (K MT) Table 80. Latin America Xeloda Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Xeloda Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Xeloda Sales by Country (2016-2021) & (K MT) Table 84. Middle East and Africa Xeloda Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Xeloda Revenue Market Share by Country (2016-2021) Table 87. Roche Corporation Information Table 88. Roche Description and Business Overview Table 89. Roche Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 90. Roche Xeloda Product Table 91. Roche Recent Development Table 92. Teva Corporation Information Table 93. Teva Description and Business Overview Table 94. Teva Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 95. Teva Product Table 96. Teva Recent Development Table 97. Mylan Corporation Information Table 98. Mylan Description and Business Overview Table 99. Mylan Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 100. Mylan Product Table 101. Mylan Recent Development Table 102. Hikma Corporation Information Table 103. Hikma Description and Business Overview Table 104. Hikma Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 105. Hikma Product Table 106. Hikma Recent Development Table 107. Hengrui Medicine Corporation Information Table 108. Hengrui Medicine Description and Business Overview Table 109. Hengrui Medicine Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 110. Hengrui Medicine Product Table 111. Hengrui Medicine Recent Development Table 112. Cipla Corporation Information Table 113. Cipla Description and Business Overview Table 114. Cipla Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 115. Cipla Product Table 116. Cipla Recent Development Table 117. Reliance Group Corporation Information Table 118. Reliance Group Description and Business Overview Table 119. Reliance Group Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 120. Reliance Group Product Table 121. Reliance Group Recent Development Table 122. Hetero Corporation Information Table 123. Hetero Description and Business Overview Table 124. Hetero Xeloda Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 125. Hetero Product Table 126. Hetero Recent Development Table 127. Xeloda Market Trends Table 128. Xeloda Market Drivers Table 129. Xeloda Market Challenges Table 130. Xeloda Market Restraints Table 131. Xeloda Customers List Table 132. Xeloda Distributors List Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Xeloda Product Picture Figure 2. Global Xeloda Sales Market Share by Type in 2020 & 2027 Figure 3. 500 mg Product Picture Figure 4. 150 mg Product Picture Figure 5. Global Xeloda Sales Market Share by Application in 2020 & 2027 Figure 6. Breast Cancer Figure 7. Colorectal cancer Figure 8. Stomach Cancer Figure 9. Xeloda Report Years Considered Figure 10. Global Xeloda Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Xeloda Market Size 2016-2027 (US$ Million) Figure 12. Global Xeloda Sales 2016-2027 (K MT) Figure 13. Global Xeloda Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Xeloda Sales Market Share by Region (2016-2021) Figure 15. Global Xeloda Sales Market Share by Region in 2020 Figure 16. Global Xeloda Revenue Market Share by Region (2016-2021) Figure 17. Global Xeloda Revenue Market Share by Region in 2020 Figure 18. Global Xeloda Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Xeloda Revenue in 2020 Figure 20. Xeloda Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Xeloda Sales Market Share by Type (2016-2021) Figure 22. Global Xeloda Sales Market Share by Type in 2020 Figure 23. Global Xeloda Revenue Market Share by Type (2016-2021) Figure 24. Global Xeloda Revenue Market Share by Type in 2020 Figure 25. Global Xeloda Sales Market Share by Application (2016-2021) Figure 26. Global Xeloda Sales Market Share by Application in 2020 Figure 27. Global Xeloda Revenue Market Share by Application (2016-2021) Figure 28. Global Xeloda Revenue Market Share by Application in 2020 Figure 29. China Xeloda Sales Growth Rate 2016-2027 (K MT) Figure 30. China Xeloda Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China Xeloda Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest Xeloda Players Market Share by Revenue in Xeloda in 2020 Figure 33. China Xeloda Revenue Share by Type (2016-2021) Figure 34. China Xeloda Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China Xeloda Revenue Share by Application (2016-2021) Figure 36. China Xeloda Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Xeloda Sales Growth Rate 2016-2021 (K MT) Figure 38. North America Xeloda Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Xeloda Sales Market Share by Country in 2020 Figure 40. North America Xeloda Revenue Market Share by Country in 2020 Figure 41. United States Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 42. United States Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 44. Canada Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 46. Mexico Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Xeloda Sales Growth Rate 2016-2021 (K MT) Figure 48. Europe Xeloda Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Xeloda Sales Market Share by Country in 2020 Figure 50. Europe Xeloda Revenue Market Share by Country in 2020 Figure 51. Germany Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 52. Germany Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 54. France Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. UK Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 56. UK Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 58. Italy Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 60. Russia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Xeloda Sales Growth Rate 2016-2021 (K MT) Figure 62. Asia Pacific Xeloda Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Xeloda Sales Market Share by Region in 2020 Figure 64. Asia Pacific Xeloda Revenue Market Share by Region in 2020 Figure 65. China Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 66. China Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 68. Japan Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 70. South Korea Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 72. India Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 74. Australia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 76. Indonesia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 78. Thailand Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 80. Malaysia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 82. Philippines Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 84. Vietnam Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Xeloda Sales Growth Rate 2016-2021 (K MT) Figure 86. Latin America Xeloda Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Xeloda Sales Market Share by Country in 2020 Figure 88. Latin America Xeloda Revenue Market Share by Country in 2020 Figure 89. Brazil Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 90. Brazil Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Middle East and Africa Xeloda Sales Growth Rate 2016-2021 (K MT) Figure 92. Middle East and Africa Xeloda Revenue Growth Rate 2016-2021 (US$ Million) Figure 93. Middle East and Africa Xeloda Sales Market Share by Country in 2020 Figure 94. Middle East and Africa Xeloda Revenue Market Share by Country in 2020 Figure 95. Turkey Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 96. Turkey Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. GCC Countries Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 98. GCC Countries Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Egypt Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 100. Egypt Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. South Africa Xeloda Sales Growth Rate (2016-2021) (K MT) Figure 102. South Africa Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Xeloda Value Chain Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Bottom-up and Top-down Approaches for This Report Figure 107. Data Triangulation Figure 108. Key Executives Interviewed

Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group Hetero